Jill Hallin

16PUBLICATIONS
235CO-AUTHORS
Molecular targetsCancer diagnosisCancer cell biologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Feb 04, 2026
Kras G12C- and G12D-driven lung cancers differ in oncogenic potency, immunogenicity, and relapse after Kras inhibition in mouse models.

Hai-Cheng Huang, Qing Deng, Lei Guo

|Sep 05, 2025
Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to KRASG12D Inhibitor Treatment.

Veronica Clavijo Jordan, Mozhdeh Sojoodi, Farzad Moloudi

|Jul 22, 2025
Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer.

Kristina Drizyte-Miller, Lars D Engstrom, Jeffrey A Klomp

|Jan 13, 2025
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial.

Marcelo V Negrao, Alvaro G Paula, David Molkentine

|Jul 08, 2024
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer.

Julien Dilly, Megan T Hoffman, Laleh Abbassi

|Jul 08, 2024
A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer.

Anupriya Singhal, Hannah C Styers, Jonathan Rub

Pageof 3

Frequent Collaborators

11 joint publications

James G Christensen

7 joint publications

Peter Olson

6 joint publications

Lars Engstrom

4 joint publications

Laura Waters